Module 628 Residual: 0.49Mycobacterium smegmatis (strain ATCC 700084 / mc(2)155)

Summary

Residual	Motif 1 e-value	Motif 2 e-value	Conditions	Genes	version
0.49	0.00019	0.00022	77	29	20160204

Motifs

Motif 1
	e-value: 0.00019
Motif 2
	e-value: 0.00022

Module Plots

Members

MSMEG_4350 Dihydrodipicolinate reductase (EC 1.17.1.8)	MSMEG_3537 Uncharacterized protein
MSMEG_4351 Putative oxidoreductase YjgI (EC 1.-.-.-) (Short-chain dehydrogenase/reductase SDR) (EC 1.1.1.100)	MSMEG_4348 Acetolactate synthase large subunit (Thiamine pyrophosphate enzyme-like TPP-binding protein) (EC 2.2.1.6)
MSMEG_3357 Metal-dependent phosphohydrolase, HD subdomain (Metal-dependent phosphohydrolase, HD subdomain protein)	MSMEG_5216 Glyoxalase family protein (Glyoxalase/bleomycin resistance protein/dioxygenase)
MSMEG_0684 Aldehyde oxidase and xanthine dehydrogenase molybdopterin binding protein (EC 1.17.1.4) (Aldehyde oxidase and xanthine dehydrogenase, molybdopterin binding)	MSMEG_0367 O-demethylpuromycin-O-methyltransferase (EC 2.1.1.38)
MSMEG_0685 Molybdopterin dehydrogenase, FAD-binding protein (EC 1.17.1.4) (Oxidoreductase, molybdopterin-binding subunit)	MSMEG_5700 Secreted protein (Transglycosylase domain protein)
MSMEG_0686 (2Fe-2S)-binding protein (EC 1.2.99.2) (Oxidoreductase)	MSMEG_0370 Uncharacterized protein
MSMEG_3536 Major facilitator superfamily MFS_1 (Sugar transport protein)	MSMEG_0369 Uncharacterized protein
MSMEG_1621 Pyrimidine-specific ribonucleoside hydrolase RihA (EC 3.2.-.-)	MSMEG_0368 Conserved hypothetical alanine and proline rich protein (Uncharacterized protein)
MSMEG_0451 Oxidoreductase, FAD-linked (Uncharacterized protein)	MSMEG_0465 Transcriptional regulator, TetR family (Transcriptional regulator, TetR family protein)
MSMEG_0235 Probable conserved membrane protein	MSMEG_4596 Uncharacterized protein
MSMEG_0234 Metallopeptidase (PgPepO oligopeptidase Metallo peptidase MEROPS family M13) (EC 3.4.24.-)	MSMEG_0089 Chromosome condensation protein (Pirin-like protein)
MSMEG_0236 Putative conserved transmembrane protein	MSMEG_1569 Uncharacterized protein
MSMEG_4246 Conserved integral membrane protein (Probable conserved integral membrane protein)	MSMEG_0123 Uncharacterized protein
MSMEG_4247 Polyprenol-phosphate-mannose-dependent alpha-(1-2)-phosphatidylinositol mannoside mannosyltransferase (EC 2.4.1.-) (Alpha-D-mannose-alpha-(1-2)-mannosyltransferase) (Alpha-mannosyltransferase) (Alpha-ManT) (PPM-dependent mannosyltransferase) (Polyprenol-phosphate-mannose alpha-mannosyltransferase) (PPM alpha-mannosyltransferase)	MSMEG_0122 Putative periplasmic solute-binding protein (Uncharacterized protein UPF0065)
MSMEG_6389 Integral membrane indolylacetylinositol arabinosyltransferase EmbB (EC 2.4.2.34) (Probable arabinosyltransferase A) (EC 2.4.2.-)

Conditions

KO_stationary.phase_rep1

Wild.type.rep2.y

Bedaquiline.vs..DMSO.15min

Mycobacterium.smegmatis.Spheroplast.induced

Biological.replicate.2.of.6..isoniazid.treatment

WT.with.vs..without.N_dye.swap_rep1

Biological.replicate.1.of.6..negative.control

dosR.WT_Replicate1

KO_log.phase_rep1

Plogcy5plogcy3slide110norm

Biological.replicate.7.of.7..falcarinol.treatment

MB100pruR.vs..MB100.rep.4

DglnR_without.vs..with.N_rep2

WT.vs..DamtR.without.N_.dyeswap_rep2

MB100pruR.vs..MB100.rep.1

Biological.replicate.7.of.7..ethambutol.treatment

Biological.replicate.5.of.7..panaxydol.treatment

Biological.replicate.1.of.6..kanamycin.treatment

Biological.replicate.6.of.6..kanamycin.treatment

Biological.replicate.3.of.6..kanamycin.treatment

Wild.type.rep3

Bedaquiline.vs..DMSO..45min

Biological.replicate.1.of.7..falcarinol.treatment

Biological.replicate.6.of.7..falcarinol.treatment

M..smegmatis.Acid.NO.treated

Biological.replicate.3.of.7..ethambutol.treatment

Biological.replicate.4.of.6..kanamycin.treatment

WT.vs..DamtR.without.N_.dyeswap_rep1

WT_log.phase_rep2

X0.6..vs..50..air.saturation.Replicate.2

M.smegmatis_mc2_155_dMSMEG_0166_study_mutant_rep1

X0.6..vs..50..air.saturation.Replicate.4

M.smegmatis_mc2_155_dMSMEG_0166_study_mutant_rep3

M.smegmatis_mc2_155_dMSMEG_0166_study_mutant_rep2

mc2155.vs.Dcrp1.replicate.2

Slow.vs..Fast.Replicate.3

X3dbfcy3plogcy5slide607norm

JR121..pJR29.VapC..vs..JR121..pJR230..VapBC..rep4

dcpA.knockout.rep2

Biological.replicate.2.of.7..falcarinol.treatment

stphcy5plogcy3slide580norm

X2.5..vs..50..air.saturation.Replicate.4

X2.5..vs..50..air.saturation.Replicate.5

stphcy3plogcy5slide581norm

WT_log.phase_rep1

Biological.replicate.4.of.7..panaxydol.treatment

X2.5..vs..50..air.saturation.Replicate.1

Biological.replicate.2.of.7..panaxydol.treatment

WT_stationary.phase_rep2

WT_stationary.phase_rep1

Biological.replicate.6.of.6..isoniazid.treatment

X4XR.rep2

Biological.replicate.4.of.6..isoniazid.treatment

X4XR.rep1

Tet.CarD.vs.Control..Replicates.1..2..and.3.

Stationary.cultures.control.without.induction.of.I.SceI.expression..T.0...Atc.

Biological.replicate.4.of.7..falcarinol.treatment

Biological.replicate.6.of.7..ethambutol.treatment

Biological.replicate.7.of.7..panaxydol.treatment

BatchCulture_LBTbroth_ExponentialPhase_Replicate2

Biological.replicate.5.of.6..negative.control

mc2155.pMind..vs.mc2155.pMind.6189.replicate.2

X4dbfcy5plogcy3slide901norm

WT.vs..DamtR.N.surplus_.dyeswap_rep1

WT.vs..DglnR.N_starvation_rep1

mc2155.pMind..vs.mc2155.pMind.6189.replicate.1

DglnR_without.vs..with.N_dyeswap_rep2

X2XR.rep1

Wild.type.rep1.y

BatchCulture_LBTbroth_StationaryPhase_Replicate4

Plogcy5plogcy3slide113norm

BatchCulture_LBTbroth_StationaryPhase_Replicate3

M.smegmatis_mc2_155_dMSMEG_0166_study_wild.type_rep3

M.smegmatis_mc2_155_dMSMEG_0166_study_wild.type_rep2

M.smegmatis_mc2_155_dMSMEG_0166_study_wild.type_rep1

Biological.replicate.3.of.6..negative.control

X4dbfcy3plogcy5slide903norm

Comments